Publications by authors named "Neil Bhola"

Claim this Profile
S
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer.
Jennifer R Grandis, Katherine A Skorupski, Ning Cheng, Zhibin Cui, Hua Li, Neil E Bhola

Cancer Cell· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor.
Shruti Lal, Neil E Bhola, Bee-Chun Sun, Yuping Chen, Tom Huang

Cancer Res Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
Neil E Bhola, Christian Njatcha, Lanlin Hu, Eliot D Lee, Jamie V Shiah

Head Neck· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.
Mehdi Bouhaddou, Rex H Lee, Hua Li, Neil E Bhola, Rachel A O'Keefe

JCI Insight· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.
Danielle L Swaney, Dana J Ramms, Zhiyong Wang, Jisoo Park, Yusuke Goto, Neil Bhola

Science· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells.
Anindita Chakrabarty, Sreeraj Surendran, Neil E Bhola, Vishnu S Mishra, Tasaduq Hussain Wani

Carcinogenesis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Noah D Peyser, Hua Li

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.
Rachel A O'Keefe, Neil E Bhola, David S Lee, Daniel E Johnson, Jennifer R Grandis

PLoS One· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells.
Anindita Chakrabarty, Sreeraj Surendran, Neil E Bhola, Vishnu S Mishra, Tasaduq Hussain Wani

Carcinogenesis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR inhibition sensitizes HPV and HPV head and neck squamous cell carcinoma to cisplatin.
Brandon C Leonard, Eliot D Lee, Neil E Bhola, Hua Li, Kristian K Sogaard

Oral Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for -altered head and neck cancer.
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, William E Gooding, Hua Li, Neil E Bhola

J Exp Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.
Valerie M Jansen, Neil E Bhola, Joshua A Bauer, Luigi Formisano, Kyung-Min Lee

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.
Neil E Bhola, Valerie M Jansen, James P Koch, Hua Li, Luigi Formisano

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer.
Neil E Bhola, Valerie M Jansen, Sangeeta Bafna, Jennifer M Giltnane, Justin M Balko

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER Breast Cancer.
Luigi Formisano, Kimberly M Stauffer, Christian D Young, Neil E Bhola, Angel L Guerrero-Zotano

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.
Brandon Leonard, Toni M Brand, Rachel A O'Keefe, Eliot D Lee, Yan Zeng, Neil E Bhola

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Hua Li, Yan Zeng

Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER Breast Cancer.
Luigi Formisano, Kimberly M Stauffer, Christian D Young, Neil E Bhola, Angel L Guerrero-Zotano

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients.
Toni M Brand, Stefan Hartmann, Neil E Bhola, Noah D Peyser, Hua Li

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.
Valerie M Jansen, Neil E Bhola, Joshua A Bauer, Luigi Formisano, Kyung-Min Lee

Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in mutant cancers.
Chaoyang Sun, Yong Fang, Jun Yin, Jian Chen, Zhenlin Ju, Neil H Bhola

Sci Transl Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensible approach to targeting STAT3-mediated transcription.
Neil E Bhola, Daniel E Johnson, Jennifer R Grandis

Ann Transl Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
Stefan Hartmann, Neil E Bhola, Jennifer R Grandis

Clin Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis